This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, Z.-Q.
Right arrow Articles by Li, L.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, Z.-Q.
Right arrow Articles by Li, L.-J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2007, p. 763-765, Vol. 51, No. 2
0066-4804/07/$08.00+0     doi:10.1128/AAC.01053-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China{triangledown}

Ze-Qing Wei, Xiao-Xing Du, Yun-Song Yu,* Ping Shen, Ya-Gang Chen, and Lan-Juan Li

Key Laboratory of Infectious Diseases of the Public Health Ministry, First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou, Zhejiang, China

Received 22 August 2006/ Returned for modification 16 September 2006/ Accepted 21 November 2006


arrow
ABSTRACT
 
A carbapenem-resistant isolate of Klebsiella pneumoniae producing class A carbapenemase KPC-2 was identified in Zhejiang, China. The KPC-2 gene was located on an approximately 60-kb plasmid in a genetic environment partially different from that of blaKPC-2 in the isolates from the United States and Colombia.


arrow
TEXT
 
Resistance to carbapenems in Klebsiella pneumoniae remains infrequent and is mainly caused by carbapenem-hydrolyzing ß-lactamases, including IMP-, VIM-, and KPC-type enzymes and OXA-48 (5, 9, 10). The impact of KPC-type carbapenemase is on the increase. The initial report of KPC-1 ß-lactamases involved a strain of K. pneumoniae recovered in North Carolina (16). Soon afterward, KPC-type ß-lactamases were reported in the northeastern United States among K. pneumoniae (1, 2, 11, 15), Klebsiella oxytoca (17), Salmonella enterica (7), and Enterobacter sp. (4) isolates. Recently, K. pneumoniae and Escherichia coli isolates producing KPC-2 were reported in Medellin, Colombia (12), upstate New York (6), and Israel (8).

In the present study we report on the detection of a KPC-2-producing K. pneumoniae isolate from a university hospital in Zhejiang, China.

The carbapenem-resistant K. pneumoniae ZR01 strain was isolated from the sputum of a 75-year-old patient hospitalized in the intensive care unit on 20 November 2004. The patient suffered from brain stem infarction, hypertensive disease, and coronary heart disease and had been admitted to the hospital on 19 January 2004. The patient died on 7 December 2004 of respiratory failure secondary to lower respiratory tract infection caused by the organism. During hospitalization, imipenem was repeatedly administered (total dosage of imipenem received, 80 g).

Identification of the isolate was determined by API 20E (bioMerieux). Susceptibility tests were performed by the agar dilution method according to guidelines of CLSI (formerly NCCLS) (3). K. pneumoniae ZR01 was resistant to all tested antimicrobial agents except polymyxin B and colistin (Table 1 ). MICs of imipenem and meropenem were slightly reduced in the presence of clavulanic acid.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Antimicrobial susceptibility patterns of K. pneumoniae ZR01, E. coli(pYW1), and E. coli(pYW2)

Attempts to transfer imipenem resistance from K. pneumoniae ZR01 to the rifampin-resistant strain of E. coli 600 by a mixed-broth mating procedure (14) failed. Mueller-Hinton agar (MHA) containing 1 µg/ml imipenem and 250 µg/ml rifampin was used to select the transconjugants. Plasmids of K. pneumoniae ZR01 were extracted by using the QIAGEN Plasmid Midi kit (QIAGEN) and were transformed into competent E. coli DH5{alpha}. Transformants were selected on MHA containing 1 µg/ml imipenem. The transformant, E. coli(pYW1), harbored a single plasmid with a size of approximately 60 kb, while K. pneumoniae ZR01 contained three plasmids with sizes of approximately 100 kb, 60 kb, and 2 kb (data not shown). MICs of imipenem and meropenem for the E. coli transformant were lower than those for K. pneumoniae ZR01 (Table 1). It is possible that alterations in porin expression affect the MICs of these antibiotics in K. pneumoniae strains (15, 16).

The plasmid from E. coli(pYW1) was digested by NheI, and fragments were cloned into the pGEM-T Easy vector. An imipenem-nonsusceptible E. coli DH5{alpha} derivative [named E. coli(pYW2)], containing a 2.1-kb cloned fragment, was obtained. Nucleotide sequencing of the cloned fragment revealed the presence of two open reading frames. The nucleotide sequence of orf2 (879 bp) had 100% identity with blaKPC-2 (GenBank accession number AY210886). Upstream of blaKPC-2 was orf1 (885 bp), encoding a putative 259-amino-acid protein showing significant similarity (55 to 60%) to several (putative) transposase or integrase proteins (GenBank accession numbers YP_355552.1, ZP_01384016.1, YP_583434.1, AAR98533.1, and NP_682719.1). PCR mapping and sequencing experiments using primers designed with the sequence designated by GenBank number AF481906 (KPC-I, 5'-CGGAACCTGCGGAGTGTATG-3', starting at bp 4265; and KPC-J, 5'-CAGCAGTTCAGGCCAACACC-3', starting at bp 5067) and the plasmid pYW1 as templates revealed that the sequence downstream of blaKPC-2 in pYW1 was identical to that present downstream of the blaKPC-2 genes in isolates from the United States and Colombia (GenBank accession numbers AF481906 and DQ523564). Interestingly, this structure was also found downstream of blaKPC-1 (GenBank accession number AF297554) (Fig. 1), suggesting that the putative transposase gene present downstream of KPC-type genes might be involved in the mobility of KPC genes. No discernible epidemiological linkage could be established between K. pneumoniae ZR01 and KPC-2-producing isolates from the United States, according to the patient record.


Figure 1
View larger version (9K):
[in this window]
[in a new window]

  		FIG. 1. Comparison of the blaKPC genetic contexts in different plasmids. In this study, downstream of blaKPC-2 a putative transposase gene (PT), which was identical to that detected downstream of blaKPC genes in plasmids from the United States (GenBank accession numbers AF297554 and AF481906) and Colombia (GenBank accession number DQ523564), was detected. Upstream of blaKPC-2 an open reading frame (orf1), which was different from the putative transposase helper protein gene (PTHP) found upstream of blaKPC genes in other KPC-2-encoding plasmids, was detected.

Crude cell lysates were prepared by ultrasonication from K. pneumoniae ZR01, E. coli(pYW1), and E. coli(pYW2), as described previously (14). ß-Lactamases were characterized by isoelectric focusing with the PhastSystem (Pharmacia, Uppsala, Sweden) according to established methods. The results showed that K. pneumoniae ZR01 had three ß-lactamase bands of pI 8.2, 6.7, and 5.4 (data not shown). The presence of TEM-1, SHV-12, and KPC-2 genes in K. pneumoniae ZR01 was confirmed by PCR and sequencing. E. coli(pYW1) showed a single ß-lactamase band of pI 6.7, in agreement with the production of KPC-2 (data not shown). This indicated that plasmid pYW1 carried only the KPC-2 ß-lactamase gene, unlike the KPC-2-encoding plasmid from S. enterica, which also carried a blaTEM-1 gene (7), and the KPC-2-encoding plasmid from K. oxytoca, which also carried a blaTEM-1 and a blaSHV-46 gene (17). E. coli(pYW2) showed two bands of pI 6.7 and 5.4 (the latter corresponding to TEM-1 from the pGEM-T Easy vector).

In China, carbapenems were widely used to treat serious gram-negative nosocomial infections. The presence of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii is increasing. Among 10 university hospitals in China, the isolation rates of carbapenem-resistant P. aeruginosa and A. baumannii were 24% and 18%, respectively (13). A strain of Enterobacter cloacae producing class A carbapenemase IMI-2 (18) was isolated in the First Affiliated Hospital of Zhejiang University. Though this isolate's occurrence was sporadic, KPC-producing strains are worrisome in the clinic, due to the potential for epidemic spread, as observed in the northeastern area of the United States (1, 2, 6, 15). In order to avoid the epidemic of strains producing KPCs, strict resistance surveillance and drug administration should be emphasized in this area.

Nucleotide sequence accession number. The nucleotide sequence of the cloning fragment obtained from K. pneumoniae ZR01 was assigned GenBank accession number DQ897687.


arrow
ACKNOWLEDGMENTS
 
This work was supported in part by a grant from the Program for New Century Excellent Talents in University (NCET-04-0552).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Infectious Disease Department, The 1st Affiliated Hospital, Medical College, Zhejiang University, Hangzhou, Zhejiang, China. Phone: 86 571 8723 6756. Fax: 86 571 8723 6755. E-mail: yvys119{at}163.com. Back

{triangledown} Published ahead of print on 4 December 2006. Back


arrow
REFERENCES
 
    1
  1. Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, and J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin. Infect. Dis. 39:55-60.[CrossRef][Medline]
    2. 2
  2. Bratu, S., M. Mooty, S. Nichani, D. Landman, C. Gullans, B. Pettinato, U. Karumudi, P. Tolaney, and J. Quale. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020.[Abstract/Free Full Text]
    3. 3
  3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A6. Clinical and Laboratory Standards Institute, Wayne, Pa.
    4. 4
  4. Hossain, A., M. J. Ferraro, R. M. Pino, R. B. Dew III, E. S. Moland, T. J. Lockhart, K. S. Thomson, R. V. Goering, and N. D. Hanson. 2004. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob. Agents Chemother. 48:4438-4440.[Abstract/Free Full Text]
    5. 5
  5. Ikonomidis, A., D. Tokatlidou, I. Kristo, D. Sofianou, A. Tsakris, P. Mantzana, S. Pournaras, and A. N. Maniatis. 2005. Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a blaVIM-1 metallo-ß-lactamase gene. J. Clin. Microbiol. 43:5344-5347.[Abstract/Free Full Text]
    6. 6
  6. Lomaestro, B. M., E. H. Tobin, W. Shang, and T. Gootz. 2006. The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin. Infect. Dis. 43:e26-e28.[CrossRef][Medline]
    7. 7
  7. Miriagou, V., L. S. Tzouvelekis, S. Rossiter, E. Tzelepi, F. J. Angulo, and J. M. Whichard. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47:1297-1300.[Abstract/Free Full Text]
    8. 8
  8. Navon-Venezia, S., I. Chmelnitsky, A. Leavitt, M. J. Schwaber, D. Schwartz, and Y. Carmeli. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101.[Abstract/Free Full Text]
    9. 9
  9. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.[CrossRef][Medline]
    10. 10
  10. Poirel, L., C. Héritier, V. Tolün, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22.[Abstract/Free Full Text]
    11. 11
  11. Smith Moland, E., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.[Abstract/Free Full Text]
    12. 12
  12. Villegas, M. V., K. Lolans, A. Correa, C. J. Suarez, J. A. Lopez, M. Vallejo, J. P. Quinn, and Colombian Nosocomial Resistance Study Group. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob. Agents Chemother. 50:2880-2882.[Abstract/Free Full Text]
    13. 13
  13. Wang, H., M. Chen, Y. Ni, D. Chen, Z. Sun, Y. Chen, W. Zhao, X. Zou, Y. Yu, Z. Hu, X. Huang, Y. Xu, X. Xie, Y. Chu, Q. Wang, Y. Mei, B. Tian, P. Zhang, Q. Kong, X. Yu, and Y. Pan. 2005. Antimicrobial resistance analysis among nosocomial gram negative bacilli from 10 teaching hospitals in China. Chin. J. Lab. Med. 28:1295-1303. (In Chinese.)
    14. 14
  14. We, Z. Q., Y. G. Chen, Y. S. Yu, W. X. Lu, and L. J. Li. 2005. Nosocomial spread of multi-resistant Klebsiella pneumoniae containing a plasmid encoding multiple ß-lactamases. J. Med. Microb. 54:885-888.
    15. 15
  15. Woodford, N., P. M. Tierno, Jr., K. Young, L. Tysall, M. F. Palepou, E. Ward, R. E. Painter, D. F. Suber, D. Shungu, L. L. Silver, K. Inglima, J. Kornblum, and D. M. Livermore. 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48:4793-4799.[Abstract/Free Full Text]
    16. 16
  16. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolyzing ß-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.[Abstract/Free Full Text]
    17. 17
  17. Yigit, H., A. M. Queenan, J. K. Rasheed, J. W. Biddle, A. Domenech-Sanchez, S. Alberti, K. Bush, and F. C. Tenover. 2003. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing ß-lactamase KPC-2. Antimicrob. Agents Chemother. 47:3881-3889.[Abstract/Free Full Text]
    18. 18
  18. Yu, Y. S., X. X. Du, Z. H. Zhou, Y. G. Chen, and L. J. Li. 2006. First isolation of blaIMI-2 in an Enterobacter cloacae clinical isolate from China. Antimicrob. Agents Chemother. 50:1610-1611.[Free Full Text]

Antimicrobial Agents and Chemotherapy, February 2007, p. 763-765, Vol. 51, No. 2
0066-4804/07/$08.00+0     doi:10.1128/AAC.01053-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Shen, P., Wei, Z., Jiang, Y., Du, X., Ji, S., Yu, Y., Li, L. (2009). Novel Genetic Environment of the Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob. Agents Chemother. 53: 4333-4338 [Abstract] [Full Text]  
  • Wang, X. D., Cai, J. C., Zhou, H. W., Zhang, R., Chen, G.-X. (2009). Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated {beta}-lactamase production and OmpK36 porin deficiency. J Med Microbiol 58: 1196-1202 [Abstract] [Full Text]  
  • Stachyra, T., Levasseur, P., Pechereau, M.-C., Girard, A.-M., Claudon, M., Miossec, C., Black, M. T. (2009). In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. J Antimicrob Chemother 64: 326-329 [Abstract] [Full Text]  
  • Akpaka, P. E., Swanston, W. H., Ihemere, H. N., Correa, A., Torres, J. A., Tafur, J. D., Montealegre, M. C., Quinn, J. P., Villegas, M. V. (2009). Emergence of KPC-Producing Pseudomonas aeruginosa in Trinidad and Tobago. J. Clin. Microbiol. 47: 2670-2671 [Abstract] [Full Text]  
  • Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon-Venezia, S., Carmeli, Y., Brolund, A., Giske, C. G. (2009). Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258. Antimicrob. Agents Chemother. 53: 3365-3370 [Abstract] [Full Text]  
  • Gootz, T. D., Lescoe, M. K., Dib-Hajj, F., Dougherty, B. A., He, W., Della-Latta, P., Huard, R. C. (2009). Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital. Antimicrob. Agents Chemother. 53: 1998-2004 [Abstract] [Full Text]  
  • Endimiani, A., Hujer, A. M., Perez, F., Bethel, C. R., Hujer, K. M., Kroeger, J., Oethinger, M., Paterson, D. L., Adams, M. D., Jacobs, M. R., Diekema, D. J., Hall, G. S., Jenkins, S. G., Rice, L. B., Tenover, F. C., Bonomo, R. A. (2009). Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 63: 427-437 [Abstract] [Full Text]  
  • Wolter, D. J., Kurpiel, P. M., Woodford, N., Palepou, M.-F. I., Goering, R. V., Hanson, N. D. (2009). Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4. Antimicrob. Agents Chemother. 53: 557-562 [Abstract] [Full Text]  
  • Navon-Venezia, S., Leavitt, A., Schwaber, M. J., Rasheed, J. K., Srinivasan, A., Patel, J. B., Carmeli, Y., and the Israeli KPC Kpn Study Group, (2009). First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States. Antimicrob. Agents Chemother. 53: 818-820 [Abstract] [Full Text]  
  • Cole, J. M., Schuetz, A. N., Hill, C. E., Nolte, F. S. (2009). Development and Evaluation of a Real-Time PCR Assay for Detection of Klebsiella pneumoniae Carbapenemase Genes. J. Clin. Microbiol. 47: 322-326 [Abstract] [Full Text]  
  • Woodford, N., Zhang, J., Warner, M., Kaufmann, M. E., Matos, J., MacDonald, A., Brudney, D., Sompolinsky, D., Navon-Venezia, S., Livermore, D. M. (2008). Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 62: 1261-1264 [Abstract] [Full Text]  
  • Hindiyeh, M., Smollen, G., Grossman, Z., Ram, D., Davidson, Y., Mileguir, F., Vax, M., Ben David, D., Tal, I., Rahav, G., Shamiss, A., Mendelson, E., Keller, N. (2008). Rapid Detection of blaKPC Carbapenemase Genes by Real-Time PCR. J. Clin. Microbiol. 46: 2879-2883 [Abstract] [Full Text]  
  • Cai, J. C., Zhou, H. W., Zhang, R., Chen, G.-X. (2008). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital. Antimicrob. Agents Chemother. 52: 2014-2018 [Abstract] [Full Text]  
  • Rasheed, J. K., Biddle, J. W., Anderson, K. F., Washer, L., Chenoweth, C., Perrin, J., Newton, D. W., Patel, J. B. (2008). Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid. J. Clin. Microbiol. 46: 2066-2069 [Abstract] [Full Text]  
  • Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., Nordmann, P. (2008). Genetic Structures at the Origin of Acquisition of the {beta}-Lactamase blaKPC Gene. Antimicrob. Agents Chemother. 52: 1257-1263 [Abstract] [Full Text]  
  • Zhang, R., Yang, L., Cai, J. C., Zhou, H. W., Chen, G.-X. (2008). High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 57: 332-337 [Abstract] [Full Text]  
  • Cuzon, G., Naas, T., Demachy, M. C., Nordmann, P. (2008). Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Klebsiella pneumoniae Isolate from Greece. Antimicrob. Agents Chemother. 52: 796-797 [Full Text]  
  • Mendes, R. E., Bell, J. M., Turnidge, J. D., Yang, Q., Yu, Y., Sun, Z., Jones, R. N. (2008). Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene. Antimicrob. Agents Chemother. 52: 798-799 [Full Text]  
  • Gutierrez, O., Juan, C., Cercenado, E., Navarro, F., Bouza, E., Coll, P., Perez, J. L., Oliver, A. (2007). Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals. Antimicrob. Agents Chemother. 51: 4329-4335 [Abstract] [Full Text]  
  • Walther-Rasmussen, J., Hoiby, N. (2007). Class A carbapenemases. J Antimicrob Chemother 60: 470-482 [Abstract] [Full Text]  
  • Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J., Carmeli, Y. (2007). Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital. Antimicrob. Agents Chemother. 51: 3026-3029 [Abstract] [Full Text]  
  • Queenan, A. M., Bush, K. (2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev. 20: 440-458 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, Z.-Q.
Right arrow Articles by Li, L.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, Z.-Q.
Right arrow Articles by Li, L.-J.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»